Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from EUA

Can heat pumps be installed in older properties?

Critics claim the technology is best suited to newbuilds – but studies reveal success with retrofits and in poorly insulated homes

The Guardian - UK

WHO deliberates strategies to integrate COVID-19 vaccines with routine immunisation

WHO deliberates strategies to integrate COVID-19 vaccines with routine immunisation

WHO Southeast Asia Region begins workshop to transition from EUA to MA for COVID-19 vaccines. NRA and NCL members, WHO and TGA experts to deliberate key considerations. 3.35B COVID-19 vaccines administered in 10 countries under EUA. WHO roadmap to address public health needs and protect high priority groups.

Gas boiler lobby trying to delay UK’s heat pump plans, leak shows

Gas boiler lobby trying to delay UK’s heat pump plans, leak shows

Trade association, which promotes hydrogen for home heating, called for clean heat market mechanism to be pushed back to 2026

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Letter to DCGI seeks emergency use nod for investigational antibiotics to save lives

Intensivists and infectious diseases specialists, faced with a dire situation where effective antibiotics to treat drug-resistant infections are lacking, have called on the government to allow emergency use authorisation (EUA), as successfully done during the COVID-19 pandemic, for certain life-saving drugs.

Dow Tumbles Over 200 Points; ChannelAdvisor Shares Spike Higher

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 200 points on Tuesday. All the three major indices recorded their third weekly loss in a row, with the Dow dropping around 3%, and the S&P 500 down around 3.3%.

Why HyreCar Is Trading Higher By 60%, Here Are 63 Stocks Moving In Tuesday's Mid-Day Session

Gainers HyreCar Inc. (NASDAQ: HYRE) jumped 60% to $1.2680 after the company announced it has received a $100 million revolving line of credit from a premier global investment bank and Medalist Partners.

US Stocks Trade Lower; Dow Drops Over 100 points

U.S. stocks traded lower this morning, with the Dow Jones dropping over 100 points on Tuesday. All the three major indices recorded their third weekly loss in a row, with the Dow dropping around 3%, and the S&P 500 down around 3.3%. Equity markets in the US were closed on…

inkl

Read news from The Economist, FT, and more,
with one subscription

Novavax (NVAX) Down As EU Adds Side Effects To COVID Jab Label

Novavax (NVAX) Down As EU Adds Side Effects To COVID Jab Label

Shares of Novavax (NASDAQ: NVAX) fell 26.2% on Jul 14, after the European Medicines Agency's (TSE: EMA) Pharmacovigilance Risk Assessment Committee ("PRAC") updated the product label of Nuvaxovid, the company's COVID-19 vaccine, to include some potential side effects like severe aller

Paxlovid and rebound Covid-19 infections: What you need to know

Paxlovid and rebound Covid-19 infections: What you need to know

Some people who take Pfizer's oral antiviral for Covid-19 report testing negative after treatment only to test positive again days later.

Veru Seeks FDA Emergency Use Nod For Its COVID-19 Treatment

Veru Seeks FDA Emergency Use Nod For Its COVID-19 Treatment

Veru Inc (NASDAQ:VERU) has submitted an emergency use authorization (EUA) for sabizabulin application to FDA for COVID-19 treatment. The application covers moderate to severe hospitalized COVID-19 patients at high risk for developing Acute Respiratory Distress Syndrome (ARDS). The EUA submission is based on the positive results from the Phase 3 COVID-19 clinical trial…

Molecular Partners, Novartis Note EUA For COVID-19 Therapy May Need Additional Data

Molecular Partners, Novartis Note EUA For COVID-19 Therapy May Need Additional Data

Molecular Partners AG (NASDAQ:MOLN) has provided an update regarding the Emergency Use Application (EUA) for ensovibep, a DARPin antiviral therapeutic candidate to treat COVID-19. The Company says that EUA, in review with the FDA, may require additional clinical data to be authorized. Vas Narasimhan also noted that the current omicron wave of SARS-Cov-2,…

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

European Medicines Agency

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

290,163 stories

117,733 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play